Show simple item record

Intermittent androgen suppression for rising PSA level after radiotherapy.

dc.contributor.authorCrook, J
dc.contributor.authorO'Callaghan, C
dc.contributor.authorDuncan, G
dc.contributor.authorDearnaley, D
dc.contributor.authorHigano, C
dc.contributor.authorHorwitz, E
dc.contributor.authorFrymire, E
dc.contributor.authorMalone, S
dc.contributor.authorChin, J
dc.contributor.authorNabid, A
dc.contributor.authorWarde, P
dc.contributor.authorCorbett, T
dc.contributor.authorAngyalfi, S
dc.contributor.authorGoldenberg, S
dc.contributor.authorGospodarowicz, M
dc.contributor.authorSaad, F
dc.contributor.authorLogue, John P
dc.contributor.authorHall, E
dc.contributor.authorSchellhammer, P
dc.contributor.authorDing, K
dc.contributor.authorKlotz, L
dc.date.accessioned2012-12-12T18:20:22Z
dc.date.available2012-12-12T18:20:22Z
dc.date.issued2012-09-06
dc.identifier.citationIntermittent androgen suppression for rising PSA level after radiotherapy. 2012, 367 (10):895-903 N. Engl J Meden_GB
dc.identifier.issn1533-4406
dc.identifier.pmid22931259
dc.identifier.doi10.1056/NEJMoa1201546
dc.identifier.urihttp://hdl.handle.net/10541/259245
dc.description.abstractIntermittent androgen deprivation for prostate-specific antigen (PSA) elevation after radiotherapy may improve quality of life and delay hormone resistance. We assessed overall survival with intermittent versus continuous androgen deprivation in a noninferiority randomized trial.
dc.language.isoenen
dc.rightsArchived with thanks to The New England journal of medicineen_GB
dc.subject.meshAdult
dc.subject.meshAged
dc.subject.meshAged, 80 and over
dc.subject.meshAndrogen Antagonists
dc.subject.meshChemotherapy, Adjuvant
dc.subject.meshDrug Administration Schedule
dc.subject.meshFollow-Up Studies
dc.subject.meshHumans
dc.subject.meshKaplan-Meier Estimate
dc.subject.meshMale
dc.subject.meshMiddle Aged
dc.subject.meshPrognosis
dc.subject.meshProportional Hazards Models
dc.subject.meshProstate-Specific Antigen
dc.subject.meshProstatic Neoplasms
dc.subject.meshQuality of Life
dc.subject.meshTestosterone
dc.titleIntermittent androgen suppression for rising PSA level after radiotherapy.en
dc.typeArticleen
dc.contributor.departmentBritish Columbia Cancer Agency, Cancer Centre for the Southern Interior, 399 Royal Ave., Kelowna, BC V1Y 5L3, Canada.en_GB
dc.identifier.journalThe New England Journal of Medicineen_GB
html.description.abstractIntermittent androgen deprivation for prostate-specific antigen (PSA) elevation after radiotherapy may improve quality of life and delay hormone resistance. We assessed overall survival with intermittent versus continuous androgen deprivation in a noninferiority randomized trial.


This item appears in the following Collection(s)

Show simple item record